Ironwood Pharmaceuticals Inc (IRWD)

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Wells Fargo 2016 Healthcare Conference on Wednesday, September 7, 2016 at 2:20 p.

Trade-Ideas LLC identified Ironwood Pharmaceuticals (IRWD) as a weak on high relative volume candidate

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotechnology company, today provided an update on its second quarter 2016 results and recent business activities.

I expect Allergan or another player to bid for SGYP soon.

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its second quarter 2016 investor update conference call and webcast at 4:30 p.

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Trade-Ideas LLC identified Ironwood Pharmaceuticals (IRWD) as a strong on high relative volume candidate

Stocks with insider trader activity include WTS, IRWD and SALM

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Jefferies 2016 Healthcare Conference on Friday, June 10, 2016 at 2:30 p.

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that it has closed the previously-announced transaction with AstraZeneca for the exclusive U.

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Goldman Sachs 37 th Annual Global Healthcare Conference on Tuesday, June 7, 2016 at 4:00 p.

Investors in Ironwood Pharmaceuticals Inc. saw new options begin trading today, for the July 15th expiration.

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the 2016 UBS Global Healthcare Conference on Wednesday, May 25, 2016 at 9:00 a.

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced the presentation of linaclotide-related clinical and preclinical data from the company and its collaborators during Digestive Disease Week® (DDW)...

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotechnology company, today provided an update on its first quarter 2016 results and recent business activities.

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Bank of America Merrill Lynch 2016 Health Care Conference on Tuesday, May 10, 2016 at 3:40 p.

Trade-Ideas LLC identified Ironwood Pharmaceuticals (IRWD) as a "dead cat bounce" (down big yesterday but up big today) candidate

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) announced today that it has entered into a licensing agreement with AstraZeneca plc for the exclusive U.

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its first quarter 2016 investor update conference call and webcast at 4:30 p.

Biotech company Synergy was rising by 9% on Tuesday. But is it a buy?

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today the appointment of Andrew Dreyfus, president and chief executive officer of Blue Cross Blue Shield of Massachusetts, to its board of directors.

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that top-line data from an exploratory Phase IIa clinical study indicate IW-9179 did not meaningfully reduce the severity of symptoms in patients with...

Trade-Ideas LLC identified Ironwood Pharmaceuticals (IRWD) as a strong on high relative volume candidate

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced that the company and its academic collaborators will present clinical and preclinical data on several soluble guanylate cyclase (sGC) stimulators from...

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced that it initiated a Phase IIb clinical trial of IW-3718 in patients with refractory gastroesophageal reflux disease (GERD).